Showing results (51-60 of 96) with videos related to
Sort By:
Pageof 10
Scientific Reports|December 11, 2020
FKBPL is associated with metabolic parameters and is a novel determinant of cardiovascular diseaseAndrzej S Januszewski, Chris J Watson, Vikki O'Neill, et al.Cancers|June 19, 2024
Precision Oncology, Artificial Intelligence, and Novel Therapeutic Advancements in the Diagnosis, Prevention, and Treatment of Cancer: Highlights from the 59th Irish Association for Cancer Research (IACR) Annual ConferenceSeodhna M Lynch, Aisling B Heeran, Caoimbhe Burke, et al.Radiation Research|January 23, 2013
Gamma irradiation and targeted radionuclides enhance the expression of the noradrenaline transporter transgene controlled by the radio-inducible p21(WAF1/CIP1) promoterAnthony G McCluskey, Robert J Mairs, Annette Sorensen, et al.Biochemical Society Transactions|March 25, 2011
The emerging role of FK506-binding proteins as cancer biomarkers: a focus on FKBPLHayley D McKeen, Donal J Brennan, Shauna Hegarty, et al.Nanomedicine (London, England)|August 26, 2021
Non-viral gene delivery utilizing RALA modulates sFlt-1 secretion, important for preeclampsiaRoss McNally, Abdelrahim Alqudah, Emma M McErlean, et al.Biochemical and Biophysical Research Communications|November 10, 2005
Identification and functional analysis of a novel bradykinin inhibitory peptide in the venoms of New World Crotalinae pit vipersRobert Leslie James Graham, Ciaren Graham, Stephen McClean, et al.Plos One|March 5, 2013
The anti-migratory effects of FKBPL and its peptide derivative, AD-01: regulation of CD44 and the cytoskeletal pathwayAnita Yakkundi, Lynn McCallum, Anthony O'Kane, et al.Cancer Gene Therapy|December 19, 2002
Bioreductive GDEPT using cytochrome P450 3A4 in combination with AQ4NHelen O McCarthy, Anita Yakkundi, Verna McErlane, et al.Molecular Therapy. Nucleic Acids|March 23, 2017
Systemic RALA/iNOS Nanoparticles: A Potent Gene Therapy for Metastatic Breast Cancer Coupled as a Biomarker of TreatmentCian M McCrudden, John W McBride, Joanne McCaffrey, et al.Cancer Nanotechnology|June 15, 2018
Gene therapy with RALA/iNOS composite nanoparticles significantly enhances survival in a model of metastatic prostate cancerCian M McCrudden, John W McBride, Joanne McCaffrey, et al.Pageof 10